Pollogen News
7 articles
growth-positive
Pollogen's Leading Home-Use Device, TriPollar Stop, Receives FDA Clearance
Pollogens RF home-use device, TriPollar Stop, has received FDA clearance for sale in the US. TriPollar Stop is indicated for the treatment of the face and neck, reducing signs of aging and improving skin strength and texture. The device uses Pollogens patented RF technology to introduce heat to the dermis, stimulating collagen and elastin fibers. TriPollar Stop has been successful in the home market outside the US and the company is excited to offer it to home users in the US. Pollogen is a global leader in the medical and home-based aesthetics markets, providing innovative solutions for skin treatments.
Customers
growth-positive
TriPollar sparks revolution in home beauty with Israeli black technology
Israeli aesthetic device company Pollogen showcases its Tripollar brand at an event in Shanghai, highlighting its integration of leading technology with its products. TriPollar, which entered China in 2014, has become a popular brand in the hi-tech beauty market. Pollogen, part of Lumenis, is a leading company in the medical and home-based aesthetics markets, known for its revolutionary TriPollar RF technology. The article emphasizes Israels innovative environment and the countrys venture capital investments. TriPollar offers safe and clinically proven results for body shaping, skin tightening, cellulite reduction, and wrinkle treatment. The company plans to offer special deals and products during the upcoming Tmall Double Eleven Shopping Festival.
Customers
growth-positive
The $250 beauty device that works like 'Photoshop for your face'
Israeli beauty-tech firm Pollogen has launched the Geneo Personal, a handheld oxygenation system that provides a super-facial in less than 10 minutes. The device stimulates oxygen from beneath the skins surface, giving clearer and fresher skin at home. Pollogen unveiled the product in an Indiegogo campaign, raising over $110,000. The Geneo Personal is priced at $109 for early-birds and will retail at $249 next year. It is expected to begin shipping in February 2019.
Customers
growth-positive
Stop V by Pollogen - The Ultimate Solution for Facial Lifting, Firming and Toning
Pollogen Ltd. is now offering the Stop V device, which combines TriPollar RF and DMA technologies to achieve a natural face-lift effect. The device targets the SMAS area and provides a non-invasive and natural face-lifting effect. The combined effect of the technologies is seen immediately, and the results are enhanced with repeated treatments. The Stop V device will be available for purchase in China from May 2018.
Customers
growth-positive
Pollogen, a Lumenis-Owned Company, Expands its Portfolio with the Divine Pro, a Holistic Approach to Repair the Signs of Aging
Pollogen Ltd., a Lumenis-owned company, has announced the release of the Divine Pro™, a multi-solution platform for facial rejuvenation. The Divine Pro incorporates clinically proven technologies and provides a holistic approach to repairing signs of aging. The company aims to grow its business by offering advanced solutions to clinics and spas. The release of the Divine Pro is expected to have a positive impact on the companys growth. The article does not mention any specific partners, customers, or financial details.
Customers
growth-positive
A Recent Clinical Comparative Study Shows Hybrid Energy (VoluDerm HE) Micro-needle RF Technology by Pollogen is a Safer and More Tolerable Treatment Option for the Ageing Neck with Minimal Pain and No Downtime
Pollogen Ltd., a global leader in the development of medical devices for the aesthetics market, has published a new article discussing the clinical results of a study on the treatment of the ageing neck. The study compared two technologies and found that Pollogens Hybrid Energy Technology, which uses micro-needles combined with radio-frequency, offers a safer and more satisfactory treatment option with minimal pain and no downtime. The study demonstrated improvement in skin laxity and general neck appearance for both treatment groups. Pollogens CEO, Moshe Shneor, expressed excitement about the studys results, stating that non-invasive procedures can achieve significant results. Pollogen provides a full line of non-invasive anti-aging treatment platforms for the aesthetic industry.
Customers
growth-positive
Lumenis buys Israeli medical aesthetic co Pollogen
Israeli medical device company Lumenis Ltd. has completed the acquisition of Pollogen Ltd., a medical aesthetic company. The financial details of the deal were not disclosed. The acquisition strengthens Lumenis position in the beauty segment and expands its product portfolio. Pollogens advanced solutions, particularly in radio-frequency technology, will enhance Lumenis offerings in the aesthetic market. The acquisition follows Lumenis acquisition by Chinas XIO Group for $510 million. Pollogens chairman and co-founder expressed excitement about joining Lumenis and further developing their products in the rapidly developing market.
Acquisition
